Enalapril Maleate And Hydrochlorothiazide Tablet
Product Images NDC 51672-4045

4 FDA label images from Sun Pharmaceutical Industries, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Enalapril Maleate And Hydrochlorothiazide (NDC 51672-4045). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Enalapril 01)

Chemical Structure (Enalapril 01)
Chemical structure diagram showing the molecular formulas of Enalapril Maleate and Hydrochlorothiazide as represented in the product data for the oral tablet dosage form by Sun Pharmaceutical Industries, Inc.*
FDA Label Image

Chemical Structure (Enalapril 02)

Chemical Structure (Enalapril 02)
Chemical structure diagram showing the molecular layout of Enalapril Maleate and Hydrochlorothiazide, including key functional groups and atomic connections.*
FDA Label Image

Principal Display Panel (5/12.5 mg Tablet Bottle Label)

Principal Display Panel (5/12.5 mg Tablet Bottle Label)
Label for Enalapril Maleate and Hydrochlorothiazide Tablets USP 5/12.5 mg oral tablets, prescription drug by Sun Pharmaceutical Industries, Inc. The label shows the NDC 51672-4045-1 and a bottle size of 100 tablets. It contains drug composition details, storage instructions to keep at 20° to 25°C, moisture protection warnings, and manufacturer/distributor information from Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.*
FDA Label Image

Principal Display Panel (10/25 mg Tablet Bottle Label)

Principal Display Panel (10/25 mg Tablet Bottle Label)
Label for Enalapril Maleate and Hydrochlorothiazide Tablets USP 10/25 mg, oral tablet form, containing 100 tablets. The label shows dosage strengths, storage instructions, and manufacturer information for Taro Pharmaceutical Industries and distribution by Taro Pharmaceuticals U.S.A., Inc. The label includes a barcode, NDC 51672-4046-1, and warnings such as 'Rx only' and keeping medication out of children's reach.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.